Trial
NCT07492888
Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Acute Respiratory Distress Syndrome
Intervention
Nogapendekin Alfa-Inbakicept (NAI)
Why stopped
New protocol developed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08